Kevin J. Appelbaum - Chief Executive Officer, Director, 10%+ Owner at Better Therapeutics, Inc.

Issuer-level insider activity

Role: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: BTTX
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Kevin J. Appelbaum since 13 Sep 2025

Reported holdings for Kevin J. Appelbaum in Better Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Better Therapeutics, Inc.

Security class: Common Stock
Shares / value: 2,406,719
Estimated value: $408,902
Report date: 31 Mar 2022
Price: $0.1699
Ownership: By Trust

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Better Therapeutics, Inc.

Security class: Common Stock
Shares / value: 6,250
Estimated value: $1,062
Report date: 31 Mar 2022
Price: $0.1699
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Better Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 235,000
Estimated value
Report date: 01 Apr 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Kevin J. Appelbaum in Better Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .